Blackstone’s RayzeBio RYZB Stock Holding History
Bought
Maintained
Sold
Blackstone's RYZB Position: Q1 2024 in Review
Blackstone sold out of RayzeBio (RYZB) in Q1 2024, closing a stake of 108,090 shares — an estimated $6.72M sold.
Blackstone first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $6.72M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.
- Blackstone reported no remaining RayzeBio position as of Q1 2024 after selling out during the quarter.
- Blackstone sold 108,090 RayzeBio shares in Q1 2024, an estimated $6.72M.
- Blackstone first reported a position in RayzeBio in Q3 2023 and held it in 2 quarters.
- Blackstone's RayzeBio position peaked at $6.72M in Q4 2023.
- 0 funds tracked by Wall St. Rank held RayzeBio as of Q1 2024.
Based on Blackstone's 13F filing for Q1 2024, filed 15 May 2024.